CY1112741T1 - Αλας φουμαρικου οξεος και 3-[2-(διμεθυλαμινο)μεθυλο-(κυκλοεξ-1-υλο)]-φαινολη και οι κρυσταλλικες μορφες της - Google Patents
Αλας φουμαρικου οξεος και 3-[2-(διμεθυλαμινο)μεθυλο-(κυκλοεξ-1-υλο)]-φαινολη και οι κρυσταλλικες μορφες τηςInfo
- Publication number
- CY1112741T1 CY1112741T1 CY20121100333T CY121100333T CY1112741T1 CY 1112741 T1 CY1112741 T1 CY 1112741T1 CY 20121100333 T CY20121100333 T CY 20121100333T CY 121100333 T CY121100333 T CY 121100333T CY 1112741 T1 CY1112741 T1 CY 1112741T1
- Authority
- CY
- Cyprus
- Prior art keywords
- cyclohex
- methyl
- salum
- fenol
- dimethylamine
- Prior art date
Links
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 title 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 title 2
- 239000013078 crystal Substances 0.000 title 1
- -1 cyclohex-1-yl Chemical group 0.000 title 1
- 239000001530 fumaric acid Substances 0.000 title 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 title 1
- DYUBYVPYECCFFH-WLHGVMLRSA-N (e)-but-2-enedioic acid;3-[2-[(dimethylamino)methyl]cyclohexyl]phenol Chemical compound OC(=O)\C=C\C(O)=O.CN(C)CC1CCCCC1C1=CC=CC(O)=C1 DYUBYVPYECCFFH-WLHGVMLRSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005034973A DE102005034973A1 (de) | 2005-07-22 | 2005-07-22 | Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen |
| EP06776326A EP1907350B1 (de) | 2005-07-22 | 2006-07-20 | Salz von fumarsäure und 3- (2-dimethylamino) methyl- ( cyclohex-1-yl) ) phenol un dessen kristalline formen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1112741T1 true CY1112741T1 (el) | 2016-02-10 |
Family
ID=37101332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121100333T CY1112741T1 (el) | 2005-07-22 | 2012-04-04 | Αλας φουμαρικου οξεος και 3-[2-(διμεθυλαμινο)μεθυλο-(κυκλοεξ-1-υλο)]-φαινολη και οι κρυσταλλικες μορφες της |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1907350B1 (enExample) |
| JP (1) | JP5205260B2 (enExample) |
| AR (1) | AR057673A1 (enExample) |
| AT (1) | ATE540919T1 (enExample) |
| CA (1) | CA2615741A1 (enExample) |
| CY (1) | CY1112741T1 (enExample) |
| DE (1) | DE102005034973A1 (enExample) |
| DK (1) | DK1907350T3 (enExample) |
| ES (1) | ES2380799T3 (enExample) |
| PE (1) | PE20070375A1 (enExample) |
| PL (1) | PL1907350T3 (enExample) |
| PT (1) | PT1907350E (enExample) |
| SI (1) | SI1907350T1 (enExample) |
| WO (1) | WO2007009793A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19525137C2 (de) * | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
| DE10000312A1 (de) * | 2000-01-05 | 2001-07-12 | Gruenenthal Gmbh | Substituierte Aminomethyl-Phenyl-Cyclohexanderivate |
| DE10218862A1 (de) * | 2002-04-26 | 2003-11-06 | Gruenenthal Gmbh | Verfahren zur Chlorierung tertiärer Alkohole |
| DE10233048A1 (de) * | 2002-07-19 | 2004-01-29 | Grünenthal GmbH | Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken |
| DE10356362A1 (de) * | 2003-11-28 | 2005-06-23 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen |
-
2005
- 2005-07-22 DE DE102005034973A patent/DE102005034973A1/de not_active Withdrawn
-
2006
- 2006-07-20 SI SI200631292T patent/SI1907350T1/sl unknown
- 2006-07-20 PL PL06776326T patent/PL1907350T3/pl unknown
- 2006-07-20 CA CA002615741A patent/CA2615741A1/en not_active Abandoned
- 2006-07-20 JP JP2008521895A patent/JP5205260B2/ja not_active Expired - Fee Related
- 2006-07-20 PT PT06776326T patent/PT1907350E/pt unknown
- 2006-07-20 WO PCT/EP2006/007161 patent/WO2007009793A1/de not_active Ceased
- 2006-07-20 DK DK06776326.8T patent/DK1907350T3/da active
- 2006-07-20 EP EP06776326A patent/EP1907350B1/de not_active Not-in-force
- 2006-07-20 ES ES06776326T patent/ES2380799T3/es active Active
- 2006-07-20 PE PE2006000872A patent/PE20070375A1/es not_active Application Discontinuation
- 2006-07-20 AT AT06776326T patent/ATE540919T1/de active
- 2006-07-21 AR ARP060103154A patent/AR057673A1/es not_active Application Discontinuation
-
2012
- 2012-04-04 CY CY20121100333T patent/CY1112741T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2380799T3 (es) | 2012-05-18 |
| JP2009502758A (ja) | 2009-01-29 |
| PT1907350E (pt) | 2012-03-29 |
| ATE540919T1 (de) | 2012-01-15 |
| CA2615741A1 (en) | 2007-01-25 |
| EP1907350B1 (de) | 2012-01-11 |
| DK1907350T3 (da) | 2012-05-07 |
| EP1907350A1 (de) | 2008-04-09 |
| WO2007009793A1 (de) | 2007-01-25 |
| JP5205260B2 (ja) | 2013-06-05 |
| SI1907350T1 (sl) | 2012-04-30 |
| PE20070375A1 (es) | 2007-05-12 |
| AR057673A1 (es) | 2007-12-12 |
| DE102005034973A1 (de) | 2007-02-15 |
| PL1907350T3 (pl) | 2012-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6300946A2 (es) | Forma cristalina de derivado de fenilamino pirimidina | |
| HN2002000156A (es) | Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización. | |
| AR077478A2 (es) | Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos | |
| ECSP099706A (es) | Nuevos derivados de n-(8-heteroariltetrahidronaftalen-2yl) y n-(5-heteroarilcroman-3-il) carboxamida para el tratamiento del dolor | |
| MX382569B (es) | Compuesto de carboxamida, sulfonamida y amina para trastornos metabolicos. | |
| AR054846A1 (es) | Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4- piridin-3-il-pirimidin-2- ilamino)-benzamida | |
| HN2010002582A (es) | Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato | |
| BR122019010008B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
| CY1114793T1 (el) | Παραγωγα αμινοπυραζολιου | |
| BRPI0608732A2 (pt) | composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto | |
| CU20060038A7 (es) | Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
| CU23616B7 (es) | Forma cristalina gamma del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
| AR060349A1 (es) | Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento del trastorno de ansiedad generalizada | |
| UY30610A1 (es) | Moduladores de mglur5 | |
| CL2009000004A1 (es) | Forma cristalina de r-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida; composicion farmaceutica que comprende a dicha forma cristalina; y uso para el tratamiento de diabetes o hiperglicemia. | |
| ECSP088889A (es) | Forma nueva de administración de racecadotril | |
| GT200500360A (es) | Compuestos organicos | |
| PE20061394A1 (es) | Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas | |
| UY32716A (es) | Compuestos de pirazina carboxamida útiles para el tratamiento de diabetes y obesidad | |
| CY1109208T1 (el) | Μηλεϊκη 3-(2-(διμεθυλαμινο) μεθυλ (κυκλοεξ-1-υλ)) φαινολη και οι κρυσταλλικες μορφες της | |
| CY1112741T1 (el) | Αλας φουμαρικου οξεος και 3-[2-(διμεθυλαμινο)μεθυλο-(κυκλοεξ-1-υλο)]-φαινολη και οι κρυσταλλικες μορφες της | |
| ECSP10010159A (es) | Ácido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-1-il]benzoico - 465 | |
| PE20081347A1 (es) | Agomelatina, hidratos, sales, cristales y composiciones de los mismos | |
| ECSP10010176A (es) | Productos quimioterapéuticos cristalinos | |
| UY29593A1 (es) | Derivados de azolopiridin-2-ona como inhibidores de lipasas y fosfolipasas |